Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10.9M
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
9.25M
-
Shares change
-
+622K
-
Total reported value, excl. options
-
$126M
-
Value change
-
+$8.37M
-
Put/Call ratio
-
0.01
-
Number of buys
-
61
-
Number of sells
-
-41
-
Price
-
$13.67
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q3 2025
147 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q3 2025.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.25M shares
of 10.9M outstanding shares and own 84.7% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (918K shares), RENAISSANCE TECHNOLOGIES LLC (801K shares), VANGUARD GROUP INC (711K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (595K shares), MORGAN STANLEY (589K shares), BANK OF AMERICA CORP /DE/ (453K shares), ACADIAN ASSET MANAGEMENT LLC (397K shares), Lido Advisors, LLC (331K shares), AQR CAPITAL MANAGEMENT LLC (311K shares), and DIMENSIONAL FUND ADVISORS LP (298K shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.